BSBenjamin Sacristan

Benjamin Sacristan

*This is an algorithmically generated author record based on publicly available information.

Benjamin Sacristan has a total of 90 co-authors. Here are the top co-authors by number of shared publications:

  • Josselin Duchateau

    Hôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, L'Institut de RYthmologie et modélisation Cardiaque (LIRYC), Université de Bordeaux , Passac Cedex

    6 shared publications
  • Nicolas Derval

    Department of Cardiac Pacing and Electrophysiology, Hopital Cardiologique du Haut-Leveque, Bordeaux University Hospital (CHU) , 1 Avenue de Magellan, Pessac Cedex 33604

    5 shared publications
  • Allan Plant

    Hôpital Cardiologique du Haut Lévêque, CHU de Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Université de Bordeaux, Bordeaux-Pessac, France

    4 shared publications
  • Francesco Notaristefano

    Department of Cardiac Pacing and Electrophysiology, Hopital Cardiologique du Haut-Leveque, Bordeaux University Hospital (CHU) , 1 Avenue de Magellan, Pessac Cedex 33604

    4 shared publications
  • Frederic Sacher

    University Hospital Bordeaux, Pessac (M.Y., P.J., F.S.).

    4 shared publications
  • Geoffroy Ditac

    Department of Cardiac Pacing and Electrophysiology, Hopital Cardiologique du Haut-Leveque, Bordeaux University Hospital (CHU) , 1 Avenue de Magellan, Pessac Cedex 33604

    4 shared publications

Latest Publications

  • Open Access

    Acute efficacy of a focal dual-energy contact force-sensing catheter vs. standard radiofrequency for anatomical ablation of persistent atrial fibrillation: a pilot study

    by Francesco Notaristefano, Nicolas Johner, Geoffroy Ditac, Allan Plant, Laurens Verhaeghe, John L Fitzgerald, Kinan Kneizeh, Karim Benali, Konstantinos Vlachos, Cinzia Monaco, et al.

  • Electrophysiological Mechanisms of Typical Atrial Flutter After Atrial Switch Operation: Critical Role of the Septal Corridor

    by Geoffroy Ditac, Nicolas Johner, Laurens Verhaeghe, Allan Plant, Francesco Notaristefano, Karim Benali, John L. Fitzgerald, Kinan Kneizeh, Konstantinos Vlachos, Cinzia Monaco, et al.

    BACKGROUND: Peritricuspid, or cavotricuspid isthmus–dependent, atrial flutter is the most common arrhythmia in patients with dextro-transposition of the great arteries treated with atrial switch surgery, but its underlying mechanisms remain poorly understood. METHODS: Twenty consecutive patients with prior atrial switch surgery referred for atrial flutter ablation were included. All underwent transbaffle puncture and high-density mapping. Anatomic barriers, activation patterns, conduction velocities, and low-voltage areas were assessed. RESULTS: In all cases of peritricuspid atrial flutter, surgical incisions defined the posterior boundary of the circuit. The narrowest segment of the reentry was consistently located within a septal corridor bounded posteriorly by the baffle incision and anteriorly by the tricuspid annulus. Slow conduction (<30 cm/s) was identified in this septal corridor in 92% of peritricuspid flutters and in 85% of patients during sinus or paced rhythm. Low-voltage areas were limited and frequently colocalized with regions of slow conduction. No patient exhibited slow conduction or low voltage at the cavotricuspid isthmus. The septal corridor was also involved in 60% of nonperitricuspid reentrant atrial tachycardias. Programmed atrial stimulation with S2 mapping accentuated conduction delay in this region, with demonstration of functional block and induction of atrial flutter. CONCLUSIONS: In patients with dextro-transposition of the great arteries corrected by atrial switch, surgical incisions define posterior boundaries and create a narrow septal corridor, or baffle-tricuspid isthmus, characterized by slow conduction and a propensity for functional block. These anatomic and electrophysiological features likely underlie the high prevalence of peritricuspid reentry in this population, representing a ubiquitous critical substrate for arrhythmia initiation and maintenance. Systematic cavotricuspid isthmus ablation should, therefore, be considered in these patients.


  • Marshall Bundle–Mediated Re-Entry After Combined Endo- and Epicardial PFA at the Mitral Isthmus Successfully Treated With VOMEI

    by Allan Plant, Francesco Notaristefano, Kinan Kneizeh, Konstantinos Vlachos, Masaaki Yokoyama, Geoffroy Ditac, Laurens Verhaeghe, John Fitzgerald, Nicolas Johner, Karim Benali, et al.


  • Ablation of Persistent Atrial Fibrillation Using a Dual-Energy Contact Force-sensing Catheter: Topography of Pulsed Field Mediated Symptoms and New Safety Challenges

    by Francesco Notaristefano, Nicolas Johner, Geoffroy Ditac, Allan Plant, Laurens Verhaeghe, John L. Fitzgerald, Kinan Kneizeh, Karim Benali, Konstantinos Vlachos, Cinzia Monaco, et al.


  • Open Access

    Perimitral Flutter Related to Pulsed Field Ablation using a pentaspline catheter: A Case Report

    by Benjamin Sacristan, Josselin Duchateau, Pierre Jais, Nicolas Derval

  • Open Access

    A Multi-Center Trained Residual Neural Network for Robust Classification of Atrial High-Rate Episodes in Remotely Monitored Pacemakers and Defibrillators

    by Lars van Krimpen, Arlene John, Anand Thiyagarajah, Tanner Carbonati, Benjamin Sacristan, Karim Benali, Antoine Da Costa, Pierre Mondoly, Rémi Chauvel, Romain Eschalier, et al.

    Remote monitoring of pacemakers and defibrillators increases patient safety but also increases clinical workload. Review of atrial high-rate episodes is particularly demanding as episodes can contain atrial tachycardia or atrial fibrillation (AT/AF), noise, or far-field oversensing (FFO). Automatic review of atrial high-rate episodes by an Artificial Intelligence (AI) model can decrease the workload of remote monitoring, provided it maintains high sensitivity for true atrial tachycardia. A residual network is trained using a center-level fourfold cross validation. The four resulting models achieved a precision of 97.2–99.4% for AT/AF, 93.1–97.7% for noise, and 75.4–94.4% for FFO, while maintaining high sensitivity 98.9–99.3% for AT/AF. The four models were combined through averaging prediction probabilities to create an ensemble model. Thresholding ensemble predictions with probability > 95% resulted in a robust ensemble model that made only two errors (<0.1%) after reviewing 3925 episodes (91.9%) of the total 4271 episodes. This shows how AI models can reliably assist in remote monitoring. Future research should be aimed at classification models for other episode types and clinical validation of AI models to assist remote monitoring of pacemakers and defibrillators.

  • Impact of Congenital Substrate 3D Imaging Reconstruction to Guide VT Catheter Ablation: The CORECA Study

    by Francis Bessière, Nicolas Combes, Hubert Cochet, Geoffroy Ditac, Laurence Iserin, Nicolas Derval, Robin Richard-Vitton, Benjamin Bouyer, Pauline Pinon, Stefano Bartoletti, et al.

    BACKGROUND: In the presence of sustained monomorphic ventricular tachycardia (VT), catheter ablation may be an option in congenital heart disease. However, the heterogeneity of underlying congenital heart disease and previous cardiac surgeries is associated with a unique and particularly complex substrate. The aim of the study was to investigate whether preprocedural 3-dimensional anatomic and substrate reconstruction based on cardiac computed tomography scan or magnetic resonance imaging could reliably identify VT substrate and ablation targets. METHODS: Consecutive patients with cardiac computed tomography or magnetic resonance imaging referred for VT ablation in 5 congenital electrophysiology centers were included. Three observers, electrophysiologists, blinded to the ablation procedure and each other, annotated potential ablation targets on 3-dimensional imaging reconstructions with a dedicated software (InHeart). Once completed, the annotations were compared between observers and with the ablation target(s) on the electroanatomical mapping generated during the procedures. RESULTS: Forty patients (mean age, 38±12 years; 67.5% male) underwent VT ablation, including 28 with a history of spontaneous sustained VT. VT was inducible in 97.5% of cases, with an acute success rate of ablation of 92.5%. Preprocedural imaging identified VT substrate in concordance with electroanatomical mapping in 87.5% of cases. There was a high degree of agreement between the observers. Positive interobserver agreement was complete in 65.0% of cases, moderate in 22.5%, and poor in 5.0%. Considering the total number of isthmuses identified by imaging in comparison with electroanatomical mapping, the sensitivity of imaging was 87.0%, and its positive predictive value was 77.0%. CONCLUSIONS: In our series, 3-dimensional anatomic reconstruction enabled identification of the critical VT substrate in most patients with complex congenital heart disease, particularly those with anatomically based reentrant circuits. Substrate target can be identified by operators with good interobserver reproducibility. This approach may guide VT ablation in these challenging cases.

  • Open Access

    Imaging‐Aided VT Ablation. Long‐Term Results From a Pilot Study

    by Benjamin Sacristan, Hubert Cochet, Benjamin Bouyer, Romain Tixier, Josselin Duchateau, Nicolas Derval, Thomas Pambrun, Marine Arnaud, Jan Charton, Geoffroy Ditac, et al.

    Background: Ventricular tachycardia (VT) ablation has become a cornerstone of patient care, especially for post‐MI VT. Several strategies have proven effective for achieving rhythm control in this population, but the workflow is highly variable and depends on the physician's experience. Aim: This study describes the initial systematic experience of VT ablation targeting wall thickness heterogeneity on a cardiac computed tomography (CT) scanner used as a surrogate for mapped VT isthmii. Methods: Consecutive patients with post‐MI VT, a CT scan, and a first VT ablation were included from January 2017 to May 2022. Targets were identified based on wall thickness heterogeneity. After image integration, ablation with > 10 grams, 40–50 W was performed with the aim of blocking the CT channels/render them non‐capturable. Only then was inducibility tested. Inducible VT, if any, were conventionally mapped and ablated with the aim of reaching non‐inducibility. Results: Thirty‐nine patients (97.4% male, age: mean LVEF 35 ± 10%) were included. The mean number of identified CT Channels was 3.6 ± 1.8/patient. Non‐inducibility was achieved in 19 (48.7%) of patients after initial imaging‐guided ablation, while at least one VT could be induced in 19 (48.7%). Among these patients, 4 had VT related to unblocked or reconnected CT‐determined VT channels, and 15 from other areas (border zone), typically with faster cycle length. After further mapping and ablation, 3 (7.7%) patients remained inducible. Mean radiofrequency time was 35 ± 19 min for CT Channels ablation, with an additional 11 ± 8 min for supplementary ablation (global mean RF time 35 ± 19 min). With a mean follow‐up of 47.8 ± 24.3 months, 61.9% (95% CI: 44.0%–75.5%) remained VT free. Conclusion: CT‐guided ablation represents a feasible and safe strategy for VT ablation in patients with an ischemic cardiomyopathy.


  • Open Access

    Imaging -aided VT ablation. Long term Results from a Pilot Study

    by Benjamin Sacristan, Hubert Cochet, Benjamin Bouyer, Romain Tixier, Josselin Duchateau, Nicolas Derval, Thomas Pambrun, Marine Arnaud, Jan Charton, Geoffroy Ditac, et al.

    Background VT ablation has become a cornerstone of patients care, especially for post MI VT. Several strategies have proven effective for achieving rhythm control in this population, but the workflow is highly variable and depends on physician experience. Aim This study describes the initial systematic experience of ventricular tachycardia (VT) ablation targeting wall thickness heterogeneity on cardiac computed tomography (CT) scanner used as surrogate for mapped VT isthmii. Methods Consecutive patients with post MI VT, a CT scan and a first VT ablation were included from January 2017 to May 2022. Targets were identified based on wall thickness heterogeneity. After image integration, ablation with >10 grams, 40-50 W was performed with the aim of blocking the CT channels/ render them non capturable. Only then inducibility was tested. Inducible VT, if any, were conventionally mapped and ablated with the aim of reaching non-inducibility. Results Thirty-nine patients (97.4% male, age: mean LVEF 35 ± 10%) were included. The mean number of identified CT Channels was 3.6 ± 1.8 / patient. Non-inducibility was achieved in 19 (48.7%) of patients after initial imaging guided ablation while at least one VT could be induced in 19 (48.7 %). Among these patients, 4 had VT related to unblocked or reconnected CT – determined VT channels, and 15 from other areas (border zone), typically with faster cycle length . After further mapping and ablation, 3 (7.7 %) patients remained inducible. Mean radiofrequency time was 35 ± 19 min for CT Channels ablation, with an additional 11 ± 8 min for supplementary ablation (global mean RF time 35 ± 19 min). With a mean follow-up of 47.8 ± 24.3 months, 61,9% (95% CI 44.0-75.5%) remained VT free. Conclusion CT-guided ablation represents a feasible and safe strategy for VT ablation in patients with an ischemic cardiomyopathy. Keywords: Ventricular tachycardia, catheter ablation, CT-Scan, InHeart software, imaging